Roivant Sciences Ltd. Quarterly Interest Expense in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Roivant Sciences Ltd. quarterly/annual Interest Expense history and growth rate from Q2 2020 to Q2 2024.
  • Roivant Sciences Ltd. Interest Expense for the quarter ending June 30, 2024 was $13.4M, a 50.3% increase year-over-year.
  • Roivant Sciences Ltd. Interest Expense for the twelve months ending June 30, 2024 was $39.3M, a 14.6% increase year-over-year.
  • Roivant Sciences Ltd. annual Interest Expense for 2023 was $34.8M, a 24.3% increase from 2022.
  • Roivant Sciences Ltd. annual Interest Expense for 2022 was $28M, a 297% increase from 2021.
  • Roivant Sciences Ltd. annual Interest Expense for 2021 was $7.04M, a 151% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $39.3M $13.4M +$4.49M +50.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $34.8M $7.18M -$1.4M -16.3% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-30
Q4 2023 $36.2M $9.44M +$998K +11.8% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $35.2M $9.25M +$912K +10.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $34.3M $8.91M +$6.3M +241% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $28M $8.58M +$7.1M +481% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-30
Q4 2022 $20.9M $8.45M +$6.95M +463% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 $13.9M $8.34M +$6.78M +437% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $7.14M $2.61M +$99K +3.94% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $7.04M $1.48M +$802K +119% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-28
Q4 2021 $6.24M $1.5M +$764K +104% Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $5.48M $1.55M +$944K +155% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $4.53M $2.51M +$1.72M +218% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $2.81M $673K Jan 1, 2021 Mar 31, 2021 10-K 2022-06-28
Q4 2020 $737K Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $608K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $791K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.